Dosing interval strategies for two-dose COVID-19 vaccination in 13 low- and middle-income countries of Europe: health impact modelling and benefit-risk analysis

Yang Liu, Carl AB Pearson, Frank G Sandmann, Rosanna C Barnard, Jong-Hoon Kim, CMMID COVID-19 Working Group, Stefan Flasche, Mark Jit, Kaja Abbas
doi: https://doi.org/10.1101/2021.11.27.21266930

Article usage

Article usage: November 2021 to December 2024

AbstractFullPdf
Nov 20215782109
Dec 202179938128
Jan 20221212422
Feb 2022102219
Mar 20221561527
Apr 202289112
May 20228909
Jun 202277111
Jul 20226814
Aug 20225734
Sep 20227229
Oct 202268112
Nov 20224615
Dec 20225416
Jan 20236307
Feb 20234914
Mar 202354114
Apr 20234714
May 202323310
Jun 2023954
Jul 2023624
Aug 202321107
Sep 20231743
Oct 20231418
Nov 20232274
Dec 20231302
Jan 20241626
Feb 20241522
Mar 20241478
Apr 20241145
May 2024945
Jun 20242404
Jul 202410312
Aug 202420511
Sep 20241945
Oct 20241264
Nov 202411116
Dec 2024504
Back to top
Posted November 28, 2021.
Download PDF

Supplementary Material

Data/Code
Email
Dosing interval strategies for two-dose COVID-19 vaccination in 13 low- and middle-income countries of Europe: health impact modelling and benefit-risk analysis
Yang Liu, Carl AB Pearson, Frank G Sandmann, Rosanna C Barnard, Jong-Hoon Kim, CMMID COVID-19 Working Group, Stefan Flasche, Mark Jit, Kaja Abbas
medRxiv 2021.11.27.21266930; doi: https://doi.org/10.1101/2021.11.27.21266930
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area